A detailed history of Nuveen Asset Management, LLC transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 193,129 shares of PLRX stock, worth $2.18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
193,129
Previous 211,930 8.87%
Holding current value
$2.18 Million
Previous $3.16 Million 34.24%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$10.58 - $15.61 $198,914 - $293,483
-18,801 Reduced 8.87%
193,129 $2.08 Million
Q1 2024

May 13, 2024

BUY
$14.14 - $19.59 $299,683 - $415,190
21,194 Added 11.11%
211,930 $3.16 Million
Q4 2023

Feb 14, 2024

SELL
$12.85 - $19.15 $241,669 - $360,154
-18,807 Reduced 8.98%
190,736 $3.45 Million
Q3 2023

Nov 14, 2023

BUY
$14.58 - $20.15 $9,549 - $13,198
655 Added 0.31%
209,543 $3.63 Million
Q2 2023

Aug 14, 2023

BUY
$18.12 - $30.56 $2.91 Million - $4.91 Million
160,728 Added 333.74%
208,888 $3.79 Million
Q1 2023

May 15, 2023

BUY
$18.73 - $36.26 $92,488 - $179,051
4,938 Added 11.42%
48,160 $1.28 Million
Q4 2022

Feb 14, 2023

BUY
$17.0 - $25.43 $734,774 - $1.1 Million
43,222 New
43,222 $835,000
Q2 2022

Aug 15, 2022

SELL
$4.11 - $8.75 $336,296 - $715,960
-81,824 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$7.01 - $14.1 $49,925 - $100,420
-7,122 Reduced 8.01%
81,824 $619,000
Q4 2021

Feb 14, 2022

SELL
$12.27 - $18.26 $51,288 - $76,326
-4,180 Reduced 4.49%
88,946 $1.2 Million
Q3 2021

Nov 12, 2021

SELL
$16.48 - $28.98 $277,045 - $487,182
-16,811 Reduced 15.29%
93,126 $1.57 Million
Q2 2021

Aug 16, 2021

BUY
$28.05 - $37.69 $831,963 - $1.12 Million
29,660 Added 36.95%
109,937 $3.2 Million
Q1 2021

May 17, 2021

BUY
$24.52 - $40.23 $1.4 Million - $2.3 Million
57,172 Added 247.44%
80,277 $3.16 Million
Q3 2020

Nov 16, 2020

BUY
$21.54 - $29.53 $497,681 - $682,290
23,105 New
23,105 $523,000

Others Institutions Holding PLRX

About PLIANT THERAPEUTICS, INC.


  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $551M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.